Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)
AstraZeneca
Alan L Ho; Marek Dedecjus; Lori J Wirth; R Michael Tuttle; William B Inabnet; Jan Tennvall; Fernanda Vaisman; Lars Bastholt; Andrew G Gianoukakis; Patrice Rodien; Ralf Paschke; Rossella Elisei; David Viola; Karen So; Danielle Carroll; Tina Hovey; Bhavana Thakre; James A Fagin; ASTRA investigator group